PeproTech(BioGems)重組人轉(zhuǎn)鐵蛋白 10g-細(xì)胞/細(xì)菌培養(yǎng)-試劑-生物在線

女人与狗锁死了视频大全|霍金死亡过程恐怖视频|无节社团简谱季免费观看|六间房直播大厅|中文字幕欧美另类精品|久久人人玩人妻潮喷内射人人|亚洲国产一区二区三区在线观看

美國PeproTech(派普泰克)公司中國代表處
PeproTech(BioGems)重組人轉(zhuǎn)鐵蛋白 10g

PeproTech(BioGems)重組人轉(zhuǎn)鐵蛋白 10g

商家詢價(jià)

產(chǎn)品名稱： PeproTech(BioGems)重組人轉(zhuǎn)鐵蛋白 10g

英文名稱： Recombinant Human Transferrin

產(chǎn)品編號： 10-366

產(chǎn)品價(jià)格： 0

產(chǎn)品產(chǎn)地： 美國

品牌商標(biāo)： BioGems

更新時(shí)間： null

使用范圍： null

美國PeproTech(派普泰克)公司中國代表處
  • 聯(lián)系人 :
  • 地址 :  江蘇省蘇州市工業(yè)園區(qū)星湖街218號A1北座4樓L03
  • 郵編 : 215123
  • 所在區(qū)域 : 江蘇
  • 電話 : 點(diǎn)擊查看
  • 傳真 : 點(diǎn)擊查看
  • 郵箱 : peprotech.infochina@thermofisher.com

?Catalogue Number :?10-366




Description


Recombinant Human Transferrin is a universal iron carrier capable of delivering iron to cells. Each 80kDA transferrin molecule can carry two iron ions in the ferric form. Recombinant Human Transferrin is manufactured animal free in a GMP facility and can be utilized to increase the quantity and quality of a wide range of cell types. Transferrin is also associated with the innate immune system, since its binding of iron can create decreased levels of free iron and impede bacterial survival. The activity is equivalent to human serum holo transferrin.








Additional Information





    
        

            
            
Source:

            		
            
            
Oryza Sativa

            		
        

        

            ?
            ?
        

        

            
            
Purity:

            		
            
            
Above ≥ 95% by SDS-PAGE% as determined by SDS-PAGE Analysis.

            		
        

        

            ?
            ?
        

        

            
            
Cross Reactivity:

            		
            
            
?

            		
        

        

            ?
            ?
        

        

            
            
Biological Activity

            		
            
            
Biological activity verified by comparison against native human transferrin in the antibody production of hybridoma cells in serum-free supplemented media.

            		
        

        

            ?
            ?
        

        

            
            
AA Sequence

            		
            
            
VPDKTVRWC AVSEHEATK CQSFRDHMK SVIPSDGPS VACVKKASY LDCIRAIAA NEADAVTLD AGLVYDAYL APNNLKPVV AEFYGSKED PQTFYYAVA VVKKDSGFQ MNQLRGKKS CHTGLGRSA GWNIPIGLL YCDLPEPRK PLEKAVANF FSGSCAPCA DGTDFPQLC QLCPGCGCS TLNQYFGYS GAFKCLKDG AGDVAFVKH STIFENLAN KADRDQYEL LCLDNTRKP VDEYKDCHL AQVPSHTVV ARSMGGKED LIWELLNQA QEHFGKDKS KEFQLFSSP HGKDLLFKD SAHGFLKVP PRMDAKMYL GYEYVTAIR NLREGTCPE APTDECKPV KWCALSHHE RLKCDEWSV NSVGKIECV SAETTEDCI AKIMNGEAD AMSLDGGFV YIAGKCGLV PVLAENYNK SDNCEDTPE AGYFAIAVV KKSASDLTW DNLKGKKSC HTAVGRTAG WNIPMGLLY NKINHCRFD EFFSEGCAP GSKKDSSLC KLCMGSGLN LCEPNNKEG YYGYTGAFR CLVEKGDVA FVKHQTVPQ NTGGKNPDP WAKNLNEKD YELLCLDGT RKPVEEYAN CHLARAPNH AVVTRKDKE ACVHKILRQ QQHLFGSNV TDCSGNFCL FRSETKDLL FRDDTVCLA KLHDRNTYE KYLGEEYVK AVGNLRKCS TSSLLEACT FRRP